Atlas FDA

VITEK 2 GRAM POSITIVE AST PANEL FOR STREPTOCOCCUS PNEUMONIAE: TRIMETHOPRIM/SULFAMETHOXAZOLE

FDA premarket approval N50510/S145 · decided 2001-06-25

Approval details

PMA number
N50510
Supplement
S145
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
VITEK 2 GRAM POSITIVE AST PANEL FOR STREPTOCOCCUS PNEUMONIAE: TRIMETHOPRIM/SULFAMETHOXAZOLE
Generic name
Susceptibility test cards, antimicrobial
Applicant
Biomerieux Vitek, Inc.
Date received
2001-04-16
Decision date
2001-06-25
Days to decision
70 days
Decision code
APPR
Product code
LTW
Advisory committee
Microbiology
Expedited review
No
Location
Hazelwood, MO
Statement
APPROVAL FOR CHANGES IN THE ANTIBIOTIC DESIGN SPECIFICATION FOR THE ANTIBIOTIC TRIMETHOPRIM/SULFAMETHOXAZOLE AT CONCENTRATIONS OF 2/38, 8/152, 16/304, AND 32/608 UG/ML TO THE VITEK 2 GRAM POSITIVE AST PANEL FOR STREPTOCOCCUS PNEUMONIAE: TRIMETHOPRIM/SULFAMETHOXAZOLE. THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME VITEK 2 AND IS INDICATED FOR USE IN VITEK 2 GRAM POSITIVE AST PANEL FOR STREPTOCOCCUS PNEUMONIAE FOR THE SUSCEPTIBILITY TESTING OF STREPTOCOCCUS PNEUMONIAE ISOLATES TO T

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
VIDAS D-DIMER (DD) ASSAY (K973819)Biomerieux Vitek, Inc.1998-03-10
VIDAS ROTAVIRUS (RTV) ASSAY (K972895)Biomerieux Vitek, Inc.1997-10-03
VIDAS ROTAVIRUS ASSAY (K965092)Biomerieux Vitek, Inc.1997-05-05
VIDAS C. DIFFICILE TOXIN A II ASSAY (K964887)Biomerieux Vitek, Inc.1997-04-08
VIDAS CHLAMYDIA BLOCKING ASSAY (K955627)Biomerieux Vitek, Inc.1996-10-07
VIDAS CREATINE KINASE MB ASSAY 30-421 (K962549)Biomerieux Vitek, Inc.1996-08-30
GRAM NEGATIVE IDENTIFICATION PLUS CARD (K962609)Biomerieux Vitek, Inc.1996-08-30
VITEK GRAM POSITIVE IDENTIFICATION CARD (GPI) (K952095)Biomerieux Vitek, Inc.1996-03-12